Go Pro

Calian Group (TSE:CGY) Hits New 52-Week High - Here's What Happened

Calian Group logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Calian Group shares reached a new 52-week high, trading as high as C$95.31 after closing at C$85.33, while its market capitalization stood at approximately C$1.08 billion.
  • Analyst sentiment remains positive: all nine covering analysts rate the stock a Buy, with a consensus price target of C$92.06. Recent target increases range from C$90 to C$105.
  • The company reported quarterly EPS of C$1.10 on revenue of C$230.40 million and pays a quarterly dividend of $0.28 per share, equivalent to a 1.2% yield and a 39.3% payout ratio.
  • MarketBeat previews the top five stocks to own by September 1st.

Calian Group Ltd. (TSE:CGY - Get Free Report)'s stock price reached a new 52-week high on Thursday . The stock traded as high as C$95.31 and last traded at C$92.43, with a volume of 36192 shares trading hands. The stock had previously closed at C$85.33.

Wall Street Analyst Weigh In

CGY has been the subject of several recent research reports. Ventum increased their price target on Calian Group from C$94.00 to C$100.00 and gave the company a "buy" rating in a report on Monday, June 15th. Royal Bank Of Canada boosted their price objective on Calian Group from C$78.00 to C$90.00 and gave the stock an "outperform" rating in a research note on Friday, May 15th. Canaccord Genuity Group upped their target price on Calian Group from C$103.00 to C$105.00 and gave the stock a "buy" rating in a research report on Monday, June 29th. Canadian Imperial Bank of Commerce increased their target price on Calian Group from C$76.00 to C$90.00 in a research note on Friday, May 15th. Finally, Stifel Nicolaus set a C$100.00 target price on Calian Group and gave the company a "buy" rating in a research note on Wednesday, May 20th. Nine equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Calian Group presently has an average rating of "Buy" and a consensus target price of C$92.06.

Read Our Latest Research Report on Calian Group

Calian Group Stock Performance

The company has a fifty day moving average of C$81.54 and a two-hundred day moving average of C$77.19. The stock has a market capitalization of C$1.08 billion, a P/E ratio of 33.08, a price-to-earnings-growth ratio of 2.50 and a beta of 0.96. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.51 and a quick ratio of 1.20.

Calian Group (TSE:CGY - Get Free Report) last released its earnings results on Thursday, August 13th. The company reported C$1.10 EPS for the quarter. The company had revenue of C$230.40 million for the quarter. Calian Group had a return on equity of 10.35% and a net margin of 3.97%. On average, equities analysts anticipate that Calian Group Ltd. will post 4.9475219 EPS for the current year.

Calian Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 10th. Investors of record on Wednesday, June 10th were paid a dividend of $0.28 per share. The ex-dividend date was Wednesday, May 27th. This represents a $1.12 annualized dividend and a yield of 1.2%. Calian Group's dividend payout ratio (DPR) is 39.30%.

Insider Buying and Selling

In other Calian Group news, insider Patrick Belanger Houston sold 6,432 shares of Calian Group stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of C$80.91, for a total value of C$520,413.12. Following the completion of the transaction, the insider owned 22,266 shares of the company's stock, valued at C$1,801,542.06. The trade was a 22.41% decrease in their ownership of the stock. 0.63% of the stock is currently owned by corporate insiders.

Calian Group Company Profile

(Get Free Report)

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Calian Group Right Now?

Before you consider Calian Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.

While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines